Form 4 for TARS Tarsus Pharmaceuticals, Inc.
Accepted 2026-09-17 16:22:59 ET · period of report 2026-09-15 · accession 0001181186-26-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-17 16:22 | 2026-09-15 | TARS | YARNO WENDY L | Dir | M - OptEx | — | +302 | 17.0K | +2% | — |
| D | 2026-09-17 16:22 | 2026-09-15 | TARS | YARNO WENDY L | Dir | M - OptEx | $0.00 | -302 | 907 | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-15 | M | A | 302 | — | 16,956 | D | — | — | (F1) The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. |
| 2 | Derivative | Restricted Stock Units | 2026-09-15 | M | D | 302 | $0.00 | 907 | D | — · — to — | 302 Common Stock | (F2) Each RSU represents a contingent right to receive one share of the Company's common stock. (F3) RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027, subject to the non-employee director's continuous service. (F3) RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027, subject to the non-employee director's continuous service. |